Arrhythmias in Cardiac Amyloidosis: Challenges in Risk Stratification and Treatment.
Cheung CC, Roston TM, Andrade JG, Bennett MT, Davis MK.
Can J Cardiol. 2020 Mar;36(3):416-423. doi: 10.1016/j.cjca.2019.11.039. Epub 2019 Dec 12.
PMID:32145868
Automatic Internal Cardiac Defibrillator.
Iqbal AM, Butt N, Jamal SF.
2023 May 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
PMID:30855925
Strong coherence between heart rate variability and intracardiac repolarization lability during biventricular pacing is associated with reverse electrical remodeling of the native conduction and improved outcome.
Strategies to prevent infections associated with cardiovascular implantable electronic devices.
Palraj BR, Farid S, Sohail MR.
Expert Rev Med Devices. 2017 May;14(5):371-381. doi: 10.1080/17434440.2017.1322506. Epub 2017 May 4.
PMID:28434261
Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, Dalal D, Tedford R, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H.
J Am Coll Cardiol. 2011 Sep 27;58(14):1485-96. doi: 10.1016/j.jacc.2011.06.043.
PMID:21939834
Intracardiac echocardiography use and outcomes after catheter ablation of ventricular tachycardia.
Field ME, Goldstein L, Yu Lee SH, Kalsekar I, Coplan P, Wong C, Khanna R, Gold MR, Reynolds MR, Winterfield JR.